Your browser doesn't support javascript.
loading
Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry.
Kang, Jeehoon; Han, Jung-Kyu; Yang, Han-Mo; Park, Kyung Woo; Kang, Hyun-Jae; Koo, Bon-Kwon; Choo, Eun Ho; Lee, Jong-Young; Park, Sang-Don; Lim, Young-Hyo; Kim, Hyung-Min; Heo, Ji-Hyun; Kim, Hyo-Soo.
Afiliación
  • Kang J; Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea.
  • Han JK; Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Yang HM; Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea.
  • Park KW; Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea.
  • Kang HJ; Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea.
  • Koo BK; Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea.
  • Choo EH; Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-Ro Jongno-Gu, Seoul, 03080, Republic of Korea.
  • Lee JY; Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, Republic of Korea.
  • Park SD; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Lim YH; Department of Internal Medicine, Inha University Hospital, Incheon, Republic of Korea.
  • Kim HM; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
  • Heo JH; Daiichi Sankyo Korea Co., Ltd., Seoul, Republic of Korea.
  • Kim HS; Daiichi Sankyo Korea Co., Ltd., Seoul, Republic of Korea.
BMC Cardiovasc Disord ; 23(1): 6, 2023 01 09.
Article en En | MEDLINE | ID: mdl-36624388
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Sustitución de Medicamentos / Intervención Coronaria Percutánea / Clorhidrato de Prasugrel Límite: Humans Idioma: En Revista: BMC Cardiovasc Disord Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Sustitución de Medicamentos / Intervención Coronaria Percutánea / Clorhidrato de Prasugrel Límite: Humans Idioma: En Revista: BMC Cardiovasc Disord Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2023 Tipo del documento: Article